Product image of Irbotens (Irbesartan) supplied by GNH India

Irbotens

Active Ingredient:
Irbesartan
Origin:
EU

Irbotens (Irbesartan)

Irbesartan, the active ingredient in Irbotens, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is prescribed to manage high blood pressure and related cardiovascular conditions in adults. By selectively blocking AT1 receptors, it helps lower vascular resistance and reduces fluid retention, supporting patients with hypertension, diabetic kidney disease, or heart failure.

GNH India supplies Irbotens as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Vian S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan is an angiotensin II receptor blocker used to treat conditions related to the renin‑angiotensin system.

  • Hypertension: lowers blood pressure and reduces risk of cardiovascular events.
  • Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.
  • Heart failure: improves symptoms and reduces hospitalizations in patients with reduced ejection fraction.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors on vascular smooth muscle, adrenal gland, and renal tubular cells. Blocking angiotensin II binding prevents vasoconstriction, aldosterone release, and sodium‑water retention, producing vasodilation, reduced blood volume, and lower systemic pressure. The inhibition also diminishes sympathetic activation and cardiac remodeling.

Side Effects

Irbesartan may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Dizziness: light‑headed sensation, especially after standing.
  • Headache: mild to moderate pain in the head.
  • Fatigue: feeling unusually tired or weak.
  • Hyperkalemia: elevated blood potassium levels.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat that may compromise breathing.
  • Renal impairment: worsening kidney function, indicated by increased serum creatinine.
  • Hepatic injury: signs of liver damage such as jaundice or elevated enzymes.
  • Severe hypotension: marked drop in blood pressure causing fainting.

Precautions & Warnings

When prescribing Irbesartan, clinicians should consider several safety considerations to minimize risk.

  • Renal function: monitor serum creatinine and potassium, especially in patients with pre‑existing kidney disease.
  • Pregnancy: contraindicated in pregnancy (Category D) due to risk of fetal toxicity.
  • Hyperkalemia: avoid use with potassium‑sparing diuretics or supplements.
  • Volume depletion: assess for dehydration before initiating therapy.
  • Drug interactions: review concomitant medications that affect the renin‑angiotensin system.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Avoid Interactions

Irbesartan can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • ACE inhibitors or aliskiren: combined use may cause excessive potassium rise and renal dysfunction.
  • Potassium‑rich supplements or potassium‑sparing diuretics: increase risk of hyperkalemia.
  • NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely)

  • Diuretics (thiazides): may enhance hypotensive effect; monitor blood pressure.
  • Lithium: increased lithium levels; monitor for toxicity.
  • Cyclosporine or tacrolimus: may increase serum creatinine; assess renal function.

Frequently Asked Questions

Irbotens contains irbesartan, an angiotensin II receptor blocker indicated for the treatment of hypertension, diabetic nephropathy and heart failure. It helps lower blood pressure, slows kidney damage in diabetes, and improves symptoms in patients with reduced‑ejection‑fraction heart failure.

Irbesartan selectively blocks AT1 receptors for angiotensin II, preventing the hormone from causing vasoconstriction, aldosterone release, and sodium‑water retention. The result is vasodilation, reduced blood volume, and lower systemic blood pressure, which benefits cardiovascular and renal conditions.

The appropriate dose of Irbotens is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Irbotens is classified as pregnancy Category D, indicating evidence of fetal risk and it is contraindicated in pregnancy. It should not be used by pregnant women. Caution is advised during breastfeeding; the drug may pass into breast milk, so a risk‑benefit assessment is required.

To order Irbotens, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbotens (irbesartan) belongs to the ARB class, which blocks the angiotensin II receptor directly. Compared with ACE inhibitors, ARBs do not cause a cough and have a lower incidence of angioedema, while providing similar blood‑pressure‑lowering effects. Choice between them depends on patient tolerance and clinical profile.

Irbotens tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources.

Irbotens is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water. Consistency in the time of day helps maintain stable blood‑pressure control.

Serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension, significant hyperkalemia, and worsening renal function. Patients should seek immediate medical attention if they experience rapid swelling, difficulty breathing, fainting, or a sudden rise in blood potassium or creatinine levels.

Irbotens should not be used by individuals with known hypersensitivity to irbesartan or any ARB component, pregnant women, or patients with severe hepatic impairment. Caution is advised in those with bilateral renal artery stenosis, severe kidney disease, or elevated serum potassium levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT